NASDAQ
No price data available for this timeframe.
AnaptysBio, Inc. (ANAB) has a price/fcf ratio of 45.80x as of Monday, May 25, 2026. This represents a 796.10% increase compared to its 12-month average of -6.58x. The price-to-free-cash-flow ratio measures a stock's price relative to its free cash flow per share, reflecting how efficiently a company generates cash.